Biotage AB (publ) (BITGF)

Market Cap	1.20B
Revenue (ttm)	195.36M
Net Income (ttm)	25.40M
Shares Out	n/a
EPS (ttm)	0.32
PE Ratio	47.21
Forward PE	47.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	636
Open	14.87
Previous Close	14.45
Day's Range	14.87 - 14.87
52-Week Range	8.77 - 18.52
Beta	0.85
RSI	51.20
Earnings Date	Aug 6, 2025

About Biotage AB

Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1969
• Employees: 680
• Stock Exchange: OTCMKTS
• Ticker Symbol: BITGF

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial numbers in SEK